Alx Oncology Holdings (ALXO) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,178.57% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 70.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.69% |
| Dec 31, 2025 | 20.75% |
| Sep 30, 2025 | 29.31% |
| Jun 30, 2025 | 35.53% |
| Mar 31, 2025 | 18.31% |
| Dec 31, 2024 | 42.39% |
| Sep 30, 2024 | 53.23% |
| Jun 30, 2024 | 9.52% |
| Mar 31, 2024 | 4.05% |
| Dec 31, 2023 | -22.67% |
| Sep 30, 2023 | -42.53% |
| Jun 30, 2023 | -3.70% |
| Mar 31, 2023 | -23.33% |
| Dec 31, 2022 | -7.14% |
| Sep 30, 2022 | -42.62% |
| Jun 30, 2022 | -102.50% |
| Dec 31, 2021 | 31.08% |